Melatonin Unimedic Pharma 1 mg/ml drink for children with ADHD and insomnia now available in the Belgian market

Unimedic Pharma AB, in partnership with its distributor TwinPharma BV, has launched Melatonin Unimedic Pharma 1 mg/ml drink in Belgium.

Johan Frödin, CEO of Unimedic Pharma says: "This marks a significant step for children with ADHD and insomnia. Our commitment to innovation and patient care drives us to develop solutions that address unmet medical needs, and we are very proud to offer this treatment option to both healthcare professionals and patients."

Gert van Alewijk, Managing Partner at TwinPharma, adds: "This melatonin 1 mg/ml drink is the first and only authorized medicinal product containing melatonin to be registered in Belgium for the treatment of insomnia in children and adolescents aged 6 to 17 years with ADHD, where healthy sleep hygiene measures alone have proven insufficient. It is supplied in a 100 ml bottle with a specially adapted 5 ml dosing syringe marked with a 0.2 ml scale, allowing for precise, individualised dosing without waste. This ensures the treatment remains cost-effective in both the short and medium term."

About Melatonin Unimedic Pharma 1 mg/ml drink
Melatonin 1 mg/ml drink contains the active substance melatonin – a hormone naturally produced by the body that helps regulate the sleep–wake cycle. Melatonin Unimedic Pharma 1 mg/ml drink is approved for the treatment of insomnia in children and adolescents (aged 6–17 years) with Attention Deficit Hyperactivity Disorder (ADHD), when good sleep hygiene alone is insufficient. It is also approved for the short-term treatment of jetlag in adults."

About Unimedic Pharma AB
Unimedic Pharma is a fully integrated Swedish specialty pharma company with extensive experience in marketing, sales, and drug development. Unimedic Pharma partner with pharmaceutical companies for in- and out-licensing of niche and original pharmaceuticals in the Nordic and international markets. Learn more at www.unimedicpharma.se.

About TwinPharma BV
TwinPharma specialises in the commercialisation of specialised pharmaceuticals in the Benelux. The company is well-respected and trusted. It improves healthcare by bringing unmet medical treatments to Belgium, such as Melatonin Unimedic Pharma 1 mg/ml drink for the treatment of insomnia in children and adolescents aged 6 to 17 years with ADHD, where measures for a healthy sleep rhythm have not helped sufficiently. TwinPharma is a member of the Your Pharma Partner in Europe alliance.
Learn more at www.twinpharma.com.